JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients

被引：0
作者：
Roberta Mancuso
Marina Saresella
Ambra Hernis
Ivana Marventano
Cristian Ricci
Simone Agostini
Marco Rovaris
Domenico Caputo
Mario Clerici
机构：
[1] ONLUS,Don C. Gnocchi Foundation
[2] University of Milan,Department of Physiopathology and Transplantation
来源：
Journal of Translational Medicine | / 10卷
关键词：
Cell mediated immunity; Natalizumab; MS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
    Mancuso, Roberta
    Saresella, Marina
    Hernis, Ambra
    Marventano, Ivana
    Ricci, Cristian
    Agostini, Simone
    Rovaris, Marco
    Caputo, Domenico
    Clerici, Mario
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [2] JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients
    Serena Delbue
    Francesca Elia
    Camilla Carloni
    Valentina Pecchenini
    Diego Franciotta
    Matteo Gastaldi
    Elena Colombo
    Lucia Signorini
    Silvia Carluccio
    Anna Bellizzi
    Roberto Bergamaschi
    Pasquale Ferrante
    Journal of NeuroVirology, 2015, 21 : 645 - 652
  • [3] JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients
    Delbue, Serena
    Elia, Francesca
    Carloni, Camilla
    Pecchenini, Valentina
    Franciotta, Diego
    Gastaldi, Matteo
    Colombo, Elena
    Signorini, Lucia
    Carluccio, Silvia
    Bellizzi, Anna
    Bergamaschi, Roberto
    Ferrante, Pasquale
    JOURNAL OF NEUROVIROLOGY, 2015, 21 (06) : 645 - 652
  • [4] Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab
    Lin, Jerry
    Bettin, Peggy
    Lee, John K.
    Ho, Joseph K.
    Sadiq, Saud A.
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 261 (1-2) : 123 - 128
  • [5] JC-virus seroconversion in multiple sclerosis patients receiving natalizumab
    Outteryck, Olivier
    Zephir, Helene
    Salleron, Julia
    Ongagna, Jean-Claude
    Etxeberria, Ana
    Collongues, Nicolas
    Lacour, Arnaud
    Fleury, Marie-Celine
    Blanc, Frederic
    Giroux, Marianne
    de Seze, Jerome
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 822 - 829
  • [6] JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
    Lanzillo, Roberta
    Liuzzi, Raffaele
    Vallefuoco, Luca
    Moccia, Marcello
    Amato, Luca
    Vacca, Giovanni
    Vacchiano, Veria
    Portella, Giuseppe
    Morra, Vincenzo Brescia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 807 - 814
  • [7] Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
    van Lierop, Z. Y. G. J.
    Toorop, A. A.
    Coerver, E. M. E.
    Willemse, E. A. J.
    Strijbis, E. M. M.
    Kalkers, N. F.
    Moraal, B.
    Barkhof, F.
    Teunissen, C. E.
    Killestein, J.
    van Kempen, Z. L. E.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [8] Erythroblastaemia in natalizumab-treated patients with multiple sclerosis
    La Gioia, Sara
    Seghezzi, Michela
    Barcella, Valeria
    Dominoni, Paola
    Mecca, Tommaso
    Frigeni, Barbara
    Conti, Marta Zaffira
    Vedovello, Marcella
    Vidali, Matteo
    Rottoli, Mariarosa
    Buoro, Sabrina
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 141 - 144
  • [9] Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
    Heesen, Christoph
    Kleiter, Ingo
    Nguyen, Franziska
    Schaeffler, Nina
    Kasper, Juergen
    Koepke, Sascha
    Gaissmaier, Wolfgang
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1507 - 1512
  • [10] Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
    Milton H. Werner
    DeRen Huang
    Journal of NeuroVirology, 2016, 22 : 871 - 875
12345